indapamide has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 2 studies
Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a 50-year-old hypertensive woman on Indapamide presenting with malaise, dizziness and serum sodium less than 100mmol/l who developed osmotic demyelination syndrome after correction of the hyponatremia." | 3.91 | Plasmapheresis to treat Osmotic Demyelination Syndrome from overly rapid plasma sodium correction. ( Chia, YK; Dhayalen, K; Fung, YK; Gayathri, DK, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gayathri, DK | 1 |
| Dhayalen, K | 1 |
| Chia, YK | 1 |
| Fung, YK | 1 |
| Michaels, NJ | 1 |
| Lemmon, K | 1 |
| Plemel, JR | 1 |
| Jensen, SK | 1 |
| Mishra, MK | 1 |
| Brown, D | 1 |
| Rawji, KS | 1 |
| Koch, M | 1 |
| Yong, VW | 1 |
2 other studies available for indapamide and Clinically Isolated CNS Demyelinating Syndrome
| Article | Year |
|---|---|
Plasmapheresis to treat Osmotic Demyelination Syndrome from overly rapid plasma sodium correction.
Topics: Antihypertensive Agents; Biomarkers; Demyelinating Diseases; Female; Humans; Hyponatremia; Indapamid | 2019 |
Aging-Exacerbated Acute Axon and Myelin Injury Is Associated with Microglia-Derived Reactive Oxygen Species and Is Alleviated by the Generic Medication Indapamide.
Topics: Aging; Animals; Antihypertensive Agents; Axons; Demyelinating Diseases; Drugs, Generic; Female; Inda | 2020 |